F. Cambien

709 total citations
16 papers, 493 citations indexed

About

F. Cambien is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, F. Cambien has authored 16 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in F. Cambien's work include Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Computational Drug Discovery Methods (2 papers). F. Cambien is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Computational Drug Discovery Methods (2 papers). F. Cambien collaborates with scholars based in France, United Kingdom and Sweden. F. Cambien's co-authors include Dominique Arveiler, Laure Lecerf, Pierre Ducimetière, Viviane Nicaud, A. Evans, G. Luc, F. Kee, Philippe Amouyel, Laurence Tiret and Odette Poirier and has published in prestigious journals such as The Lancet, Diabetes and Journal of the American Society of Nephrology.

In The Last Decade

F. Cambien

15 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Cambien France 7 271 253 139 93 82 16 493
J. D. Brunzell United States 6 371 1.4× 152 0.6× 265 1.9× 134 1.4× 42 0.5× 14 603
Y.-D. Ida Chen United States 7 232 0.9× 153 0.6× 175 1.3× 96 1.0× 29 0.4× 7 468
George C. Liu Canada 9 284 1.0× 295 1.2× 79 0.6× 184 2.0× 109 1.3× 9 706
S. Meijssen Netherlands 11 277 1.0× 162 0.6× 138 1.0× 94 1.0× 16 0.2× 13 444
David B. Jacobs United States 12 162 0.6× 99 0.4× 112 0.8× 122 1.3× 45 0.5× 17 449
R. A. DeFronzo United States 7 263 1.0× 138 0.5× 82 0.6× 101 1.1× 27 0.3× 7 507
Mikiya Usukura Japan 12 236 0.9× 137 0.5× 149 1.1× 41 0.4× 34 0.4× 20 442
Hugh M Mather United Kingdom 7 224 0.8× 65 0.3× 163 1.2× 87 0.9× 15 0.2× 9 390
J.B. Ruidavets France 8 147 0.5× 127 0.5× 154 1.1× 45 0.5× 16 0.2× 16 391
Alena Šmahelová Czechia 12 215 0.8× 49 0.2× 121 0.9× 58 0.6× 32 0.4× 42 418

Countries citing papers authored by F. Cambien

Since Specialization
Citations

This map shows the geographic impact of F. Cambien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Cambien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Cambien more than expected).

Fields of papers citing papers by F. Cambien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Cambien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Cambien. The network helps show where F. Cambien may publish in the future.

Co-authorship network of co-authors of F. Cambien

This figure shows the co-authorship network connecting the top 25 collaborators of F. Cambien. A scholar is included among the top collaborators of F. Cambien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Cambien. F. Cambien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hagedorn, Claudia, Ralph Telgmann, Boris Schmitz, et al.. (2010). P106 IDENTIFICATION AND FUNCTIONAL ANALYSES OF MOLECULAR HAPLOTYPES OF THE HUMAN OSTEOPROTEGERIN GENE PROMOTER. Atherosclerosis Supplements. 11(2). 38–38. 1 indexed citations
2.
Vionnet, Nathalie, Michel Marre, Per‐Henrik Groop, et al.. (2006). The canosinase gene (CNDP1) is not a protection factor of diabetic nephropathy in type 1 diabetics. Diabetes & Metabolism. 32. 1 indexed citations
3.
Alhenc‐Gelas, François, E. Baumelou, Philippe Beaune, et al.. (2003). Pharmacogénétique, étude du génome et développement des médicaments. Therapies. 58(3). 275–278. 2 indexed citations
4.
Hoffstedt, Johan, Odette Poirier, Fredrik Lönnqvist, et al.. (1999). Polymorphism of the human beta3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function.. Diabetes. 48(1). 203–205. 94 indexed citations
5.
Tarnow, Lise, Peter Karl Jacobsen, Peter Rossing, et al.. (1998). [The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors].. PubMed. 160(34). 4886–9. 6 indexed citations
6.
Thillet, Joëlle, Lionel Brazier, Laurence Tiret, et al.. (1997). 2.P.166 Elevated lipoprotein(a) levels in patients with myocardial infarction are not fully determined by variation at the apo(a) gene locus. The ECTIM study. Atherosclerosis. 134(1-2). 151–151. 1 indexed citations
7.
8.
Jacobsen, Peter Karl, Lise Tarnow, Peter Rossing, et al.. (1995). The insertion/deletion polymorphism in the angiotensin I-converting enzyme gene predicts the progression of diabetic nephropathy during ACE inhibition in insulin dependent diabetic patients. Journal of the American Society of Nephrology. 6(3). 450. 9 indexed citations
9.
Kee, F., James A. Weston, John Yarnell, et al.. (1995). The effect of diet on lipid, apoprotein and lipoparticle variation in the ECTIM study in Belfast.. PubMed. 43(1). 18–25. 2 indexed citations
10.
Tarnow, Lise, F. Cambien, Peter Rossing, et al.. (1994). ACE GENE POLUMORPHISM, DIABETIC NEPHROPATHY, AND CORONARY HEART DISEASE IN IDDM PATIENTS. 5. 384–391. 1 indexed citations
11.
Tiret, Laurence, Viviane Nicaud, F. Kee, et al.. (1993). Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. The Lancet. 341(8851). 991–992. 211 indexed citations
12.
Visvikis‐Siest, Sophie, Jean‐Pierre Cambou, Dominique Arveiler, et al.. (1993). Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls. Human Genetics. 90(5). 561–5. 36 indexed citations
13.
Levenson, J, et al.. (1987). Combined effects of sex and hypertension on the geometrical design of large arteries. Sexual differences in normal and hypertensive forearm arteries.. PubMed. 3(4). 617–23. 3 indexed citations
14.
Lang, Thierry, F. Cambien, J L Richard, & A. Bingham. (1987). [Mortality in cerebrovascular diseases and alcoholism in France].. PubMed. 16(28). 1351–4. 2 indexed citations
15.
Richard, J L, F. Cambien, & Pierre Ducimetière. (1981). [Epidemiologic characteristics of coronary disease in France].. PubMed. 10(14). 1111–4. 20 indexed citations
16.
Cambien, F., J. L. Richard, & Pierre Ducimetière. (1980). Familial history of coronary heart diseases and high blood pressure in relation to the prevalence of risk factors, and the incidence of coronary heart diseases. The Paris Prospective Study.. 28(1). 21–37. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026